Feasibility of adjuvant chemotherapy with doxorubicin plus docetaxel followed by sequential capecitabine in patients with node positive breast cancer.

被引：0
|
作者：
Lara, R
Mayordomo, JI
Modolell, A
Burillo, M
Sanz, J
Murillo, L
Janariz, J
Perez, V
Andres, R
Tres, A
机构：
[1] Hosp Clin Univ, Zaragoza, Spain
[2] Inst Oncol Corachan, Barcelona, Spain
[3] Hosp San Jorge, Huesca, Spain
[4] Hosp Tudela, Tudela, Spain
[5] Hosp Creu Roja De Barcelona, Barcelona, Spain
[6] Hosp Arritxaca, Murcia, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
782
引用
收藏
页码：72S / 72S
页数：1
相关论文
共 50 条
  • [1] Safety analysis of docetaxel (T) and doxorubicin (A) followed by sequential capecitabine (X) as adjuvant chemotherapy of patients with node-positive operable breast cancer (BC).
    Mayordomo, JI
    Madroñal, C
    Garcia-Lopez, MJ
    Burillo, MA
    Perez, V
    Janariz, J
    Murillo, L
    Andres, R
    Lara, R
    Lambea, J
    Sanz, IAJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 80S - 80S
  • [2] Doxorubicin followed by docetaxel versus docetaxel followed by doxorubicin in the adjuvant treatment of node positive breast cancer: Results of a feasibility study
    Cardoso, F
    Ferreira, AF
    Crown, J
    Dolci, S
    Paesmans, M
    Riva, A
    Di Leo, A
    Piccart, MJ
    [J]. ANTICANCER RESEARCH, 2001, 21 (1B) : 789 - 795
  • [3] Use of Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy for Breast Cancer
    Livi, L.
    Meattini, I.
    Cardillo, C. De Luca
    Scotti, V.
    Agresti, B.
    Franzese, C.
    Sanchez, L.
    Nori, J.
    Bertocci, S.
    Cassani, S.
    Bianchi, S.
    Cataliotti, L.
    Biti, G.
    [J]. JOURNAL OF CHEMOTHERAPY, 2011, 23 (01) : 36 - 39
  • [4] Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer.
    Natoli, C.
    Cianchetti, E.
    Ficorella, C.
    Angelucci, D.
    Grossi, S.
    Noccioli, P.
    Ricevuto, E.
    Grassadonia, A.
    Zilli, M.
    Di Giacobbe, A.
    Rispoli, A., I
    Tinari, N.
    Iacobelli, S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S150 - S150
  • [5] Doxorubicin (A) followed by docetaxel (T) versus doxorubicin plus docetaxel (AT) in the adjuvant treatment of breast cancer (BC)
    Di Leo, A
    Crown, J
    Nogaret, LM
    Duffy, K
    Bartholomeus, S
    Dolci, S
    Rowan, S
    O'Higgins, N
    Riva, A
    Piccart, MJ
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 : S41 - S41
  • [6] Feasibility study of fluorouracil/epirubicin/cyclophosphamicle (FEC75) followed by docetaxel (DOC) as adjuvant chemotherapy in Japanese patients with node positive breast cancer
    Rai, Y.
    Tanaka, M.
    Mitsuyama, M.
    Uga, T.
    Tanaka, S.
    Nanba, K.
    Furusawa, H.
    Murata, K.
    Nishimura, R.
    Oikawa, T.
    Kamada, Y.
    Maeda, S.
    Maeda, J.
    Honjyo, S.
    Iwase, H.
    Yamamoto, Y.
    Masuno, K.
    Shibuta, K.
    Kai, Y.
    Taniguchi, H.
    Yahara, T.
    Yokoyama, G.
    Yoshinaga, Y.
    Umeda, S.
    Hisamatsu, K.
    Tamura, K.
    [J]. BREAST, 2009, 18 : S54 - S54
  • [7] 5-fluoruracil, doxorubicin and ciclophosphamyde (FAC) followed by docetaxel (TXT) as adjuvant chemotherapy in node positive early breast cancer: Toxicity and safety
    Ratti, R.
    Coccorullo, Z.
    Guarneri, D.
    Addamo, G.
    Colloca, G.
    Venturino, A.
    Campora, E.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 138 - 138
  • [8] A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel plus sorafenib in women with node positive or high-risk breast cancer.
    Spigel, D. R.
    Molthrop, D.
    Peacock, N.
    Kommor, M.
    Markus, T.
    Vazquez, E.
    Greco, F. A.
    Burris, H. A.
    Hainsworth, J. D.
    Yardley, D. A.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 190S - 190S
  • [9] Sequential doxorubicin plus vinorelbine (AV) followed by docetaxel plus carboplatin (DC) as neoadjuvant chemotherapy for advanced breast cancer (BC)
    Santisteban, Marta
    De la Cruz, Susana
    Sola, Jesus Javier
    Aramendia, Jose Manuel
    Espinos, Jaime
    Garran, Cristina
    Martinez-Regueira, Fernando
    Zornoza, Gerardo
    Fernandez-Hidalgo, Oscar
    Nieto, Yago
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 86 - 86
  • [10] Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study
    Martin, Miguel
    Ruiz Simon, Amparo
    Ruiz Borrego, Manuel
    Ribelles, Nuria
    Rodriguez-Lescure, Alvaro
    Munoz-Mateu, Montserrat
    Gonzalez, Sonia
    Margeli Vila, Mireia
    Barnadas, Agusti
    Ramos, Manuel
    Del Barco Berron, Sonia
    Jara, Carlos
    Calvo, Lourdes
    Martinez-Janez, Noelia
    Mendiola Fernandez, Cesar
    Rodriguez, Cesar A.
    Martinez de Duenas, Eduardo
    Andres, Raquel
    Plazaola, Arrate
    de la Haba-Rodriguez, Juan
    Manuel Lopez-Vega, Jose
    Adrover, Encarna
    Isabel Ballesteros, Ana
    Santaballa, Ana
    Sanchez-Rovira, Pedro
    Baena-Canada, Jose M.
    Casas, Maribel
    del Carmen Camara, Mara
    Maria Carrasco, Eva
    Lluch, Ana
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) : 3788 - +
12345